The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Vaccines dominate the poultry pharmaceuticals market due to rising concerns over infectious diseases like Newcastle Disease and Avian Influenza. Regulatory restrictions on antibiotics further boost ...

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

CSL has received approval from the EC for Andembry (garadacimab) to prevent recurrent attacks of HAE in patients aged 12 ...

Founded in 1987 in the US, Gale Smith – VP of vaccine development at Novavax – invented the technique of using insect cells for producing recombinant protein vaccines. A further milestone came ...

Request Sample of the Report on Global Serum Free and Specialty Media Market 2033 - Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies, and rise ...

Spire Wealth Management bought a new position in Novavax, Inc. (NASDAQ:NVAX – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange ...